Clinical Trial Update: Sham-Controlled Rapid-Acting Neuromodulation for Depression [NA]

View source ↗

Summary

A clinical trial update describes a sham-controlled, rapid-acting neuromodulation study for major depressive disorder. Recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: University of California, Davis | Conditions: Depression - Major Depressive Disorder | NA | Status: NOT_YET_RECRUITING